JERROLD DUANE DOTSON - 30 Jun 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
VP, CFO AND SECRETARY
Signature
/s/ Jerrold D. Dotson
Issuer symbol
VTGN
Transactions as of
30 Jun 2021
Net transactions value
+$90,253
Form type
4
Filing time
02 Jul 2021, 16:10:59 UTC
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $5,925 +3,044 +30% $1.95 13,044 30 Jun 2021 Direct F1
transaction VTGN Common Stock Options Exercise $1,500 +1,000 +7.7% $1.50 14,044 30 Jun 2021 Direct
transaction VTGN Common Stock Options Exercise $78,918 +78,918 +562% $1.00* 92,962 30 Jun 2021 Direct
transaction VTGN Common Stock Options Exercise $3,910 +9,824 +11% $0.3980 102,786 30 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Options Exercise $0 -1,000 -100% $0.000000* 0 30 Jun 2021 Common Stock 1,000 $1.50 Direct
transaction VTGN Stock Option (Right to Buy) Disposed to Issuer $0 -36,707 -24% $0.000000 113,293 30 Jun 2021 Common Stock 150,000 $1.00 Direct F2, F3
transaction VTGN Stock Option (Right to Buy) Options Exercise $0 -78,918 -70% $0.000000 34,375 30 Jun 2021 Common Stock 113,293 $1.00 Direct F3
transaction VTGN Stock Option (Right to Buy) Options Exercise $0 -9,824 -6.5% $0.000000 140,176 30 Jun 2021 Common Stock 150,000 $0.3980 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).
F2 Represents stock options that were cancelled and returned to the Issuer in order to pay the exercise price associated with the exercise reported herein.
F3 25% of the shares subject to this stock option vested May 23, 2019, with the the remaining shares vesting in 1/36th installments on each monthly anniversary thereafter.
F4 Twenty-five percent (25%) of the total number of shares began vesting immediately on April 23, 2020, with the remaining shares vesting in 1/24th monthly installments thereafter.